Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090129171> ?p ?o ?g. }
- W2090129171 endingPage "901" @default.
- W2090129171 startingPage "896" @default.
- W2090129171 abstract "Urothelial cell carcinomas (UCC), including bladder cancer and upper urinary tract cancer, are the second most common malignancy of the urogenital tract after prostate cancer. It is a critical issue to differentiate accurately those patients whose tumour will recur and/or progress after initial treatment from those without recurrence and/or progression because tumours with a similar morphology behave differently. Patients undergo lifelong cystoscopic and cytology surveillance to detect subsequent tumour recurrence. New noninvasive methods for the diagnosis and surveillance of UCCs are required. DNA methylation is an important epigenetic mechanism of gene regulation and plays essential roles in tumour initiation and progression. Currently, aberrant promoter hypermethylation has been investigated in specific genes, i.e. tumour-suppressor genes, proto-oncogenes, genes involved in cell adhesion, and genes of cell cycle regulation. E-cadherin has been shown to be an independent marker of prognosis. Other genes, e.g. APC, RASSF1a, TNFRSF25, EDNRB, and p14, are implicated in tumour progression. IGFBP3 and APAF-1 are independent markers of recurrence. APAF-1 is also correlated with tumour stage and grade. In urine, hypermethylation of DAPK, RARβ, E-cadherin and p16 has been shown to have a good sensitivity and specificity for bladder cancer detection. Several studies found that analysis of hypermethylation using a panel of tumour-suppressor genes yielded superior results to cytology in the detection of bladder cancer and its progression. Hence, the different panels (e.g. RASSF1a/APC/p14, RAR_/DAPK/E-cadh/p16, p16/p14/MGMT/GSTP1, and RASSF1a/E-cadh/APC) are of interest in the detection of bladder cancer. The last panel and RASSF1a/E-cadh/APC/TNFRSF25/EDNRB are also interesting for tumour progression. There is evidence that the extent of the mutator and methylator phenotypes in UCCs differs with tumour location, perhaps suggesting that carcinogens affect the urinary tract in different ways. For all loci studied except DAPK, there was more frequent methylation in UUT-UCCs than in the bladder cancers; this difference was statistically significant for hMLH1, RARB, E-cadherin, p16 and MINT31. In contrast to UUT-UCCs, hMLH1 and MINT31 were rarely methylated in bladder tumours, suggesting that they play a role in UUT carcinogenesis but not bladder cancer." @default.
- W2090129171 created "2016-06-24" @default.
- W2090129171 creator A5034411257 @default.
- W2090129171 creator A5038667646 @default.
- W2090129171 creator A5064914239 @default.
- W2090129171 date "2009-10-01" @default.
- W2090129171 modified "2023-10-17" @default.
- W2090129171 title "Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract" @default.
- W2090129171 cites W1973297337 @default.
- W2090129171 cites W1996298672 @default.
- W2090129171 cites W1998176194 @default.
- W2090129171 cites W2000054924 @default.
- W2090129171 cites W2002195470 @default.
- W2090129171 cites W2010467196 @default.
- W2090129171 cites W2029207071 @default.
- W2090129171 cites W2042206812 @default.
- W2090129171 cites W2042686859 @default.
- W2090129171 cites W2046333444 @default.
- W2090129171 cites W2053992841 @default.
- W2090129171 cites W2057982830 @default.
- W2090129171 cites W2062146824 @default.
- W2090129171 cites W2080903931 @default.
- W2090129171 cites W2087775942 @default.
- W2090129171 cites W2089171966 @default.
- W2090129171 cites W2105935489 @default.
- W2090129171 cites W2111107512 @default.
- W2090129171 cites W2119938419 @default.
- W2090129171 cites W2123238153 @default.
- W2090129171 cites W2129430629 @default.
- W2090129171 cites W2130788521 @default.
- W2090129171 cites W2132907440 @default.
- W2090129171 cites W2153887787 @default.
- W2090129171 cites W2166174406 @default.
- W2090129171 cites W2170358006 @default.
- W2090129171 cites W2170874723 @default.
- W2090129171 cites W2316642745 @default.
- W2090129171 doi "https://doi.org/10.1111/j.1464-410x.2009.08696.x" @default.
- W2090129171 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19522860" @default.
- W2090129171 hasPublicationYear "2009" @default.
- W2090129171 type Work @default.
- W2090129171 sameAs 2090129171 @default.
- W2090129171 citedByCount "50" @default.
- W2090129171 countsByYear W20901291712012 @default.
- W2090129171 countsByYear W20901291712013 @default.
- W2090129171 countsByYear W20901291712014 @default.
- W2090129171 countsByYear W20901291712015 @default.
- W2090129171 countsByYear W20901291712016 @default.
- W2090129171 countsByYear W20901291712017 @default.
- W2090129171 countsByYear W20901291712018 @default.
- W2090129171 countsByYear W20901291712019 @default.
- W2090129171 countsByYear W20901291712022 @default.
- W2090129171 countsByYear W20901291712023 @default.
- W2090129171 crossrefType "journal-article" @default.
- W2090129171 hasAuthorship W2090129171A5034411257 @default.
- W2090129171 hasAuthorship W2090129171A5038667646 @default.
- W2090129171 hasAuthorship W2090129171A5064914239 @default.
- W2090129171 hasBestOaLocation W20901291711 @default.
- W2090129171 hasConcept C104317684 @default.
- W2090129171 hasConcept C121608353 @default.
- W2090129171 hasConcept C126322002 @default.
- W2090129171 hasConcept C142724271 @default.
- W2090129171 hasConcept C150194340 @default.
- W2090129171 hasConcept C190727270 @default.
- W2090129171 hasConcept C2778264664 @default.
- W2090129171 hasConcept C2780192828 @default.
- W2090129171 hasConcept C2780352672 @default.
- W2090129171 hasConcept C41091548 @default.
- W2090129171 hasConcept C502942594 @default.
- W2090129171 hasConcept C55493867 @default.
- W2090129171 hasConcept C555283112 @default.
- W2090129171 hasConcept C71924100 @default.
- W2090129171 hasConcept C86803240 @default.
- W2090129171 hasConceptScore W2090129171C104317684 @default.
- W2090129171 hasConceptScore W2090129171C121608353 @default.
- W2090129171 hasConceptScore W2090129171C126322002 @default.
- W2090129171 hasConceptScore W2090129171C142724271 @default.
- W2090129171 hasConceptScore W2090129171C150194340 @default.
- W2090129171 hasConceptScore W2090129171C190727270 @default.
- W2090129171 hasConceptScore W2090129171C2778264664 @default.
- W2090129171 hasConceptScore W2090129171C2780192828 @default.
- W2090129171 hasConceptScore W2090129171C2780352672 @default.
- W2090129171 hasConceptScore W2090129171C41091548 @default.
- W2090129171 hasConceptScore W2090129171C502942594 @default.
- W2090129171 hasConceptScore W2090129171C55493867 @default.
- W2090129171 hasConceptScore W2090129171C555283112 @default.
- W2090129171 hasConceptScore W2090129171C71924100 @default.
- W2090129171 hasConceptScore W2090129171C86803240 @default.
- W2090129171 hasIssue "7" @default.
- W2090129171 hasLocation W20901291711 @default.
- W2090129171 hasLocation W20901291712 @default.
- W2090129171 hasOpenAccess W2090129171 @default.
- W2090129171 hasPrimaryLocation W20901291711 @default.
- W2090129171 hasRelatedWork W1973473202 @default.
- W2090129171 hasRelatedWork W1981735078 @default.
- W2090129171 hasRelatedWork W2046980861 @default.
- W2090129171 hasRelatedWork W2068071476 @default.
- W2090129171 hasRelatedWork W2091632974 @default.
- W2090129171 hasRelatedWork W2157069906 @default.